[Assessment of Human Papillomavirus Testing on Liquid-based Cyto-screen System for Women with Atypical Squamous Cells of Undetermined Significance. Effect of Age]
Overview
Reproductive Medicine
Affiliations
Objective: Analyse the performance of human papillomavirus testing with hybrid capture II on liquid-based CYTO-screen system for women diagnosed with atypical squamous cells of undetermined significance according to the age.
Patients And Methods: Were included all women diagnosed with atypical squamous cells of undetermined significance for whom human papillomavirus testing was performed and cytological and histological procedures were available over a follow-up period of 6 to 18 months.
Results: Human papillomavirus testing was performed in 3,047 patients, and results were compared to cytological and histological follow-up diagnosis in 1,880 cases (61.7%). The sensitivity for diagnosing cervical intraepithelial neoplasia was 93.3% in women less than 30 of age and 89.7% in women more than 30 of age. Specificity was 44.9% in women less than 30 of age and 64.4% in women more than 30 of age. Likelihood ratios confirmed these results as they show a low discriminatory power in case of positive result specifically in women less than 30 of age but an excellent performance in case of negative result.
Discussion And Conclusion: The use of human papillomavirus testing after a diagnosis of atypical squamous cells of undetermined significance with the residual material of Cyto-screen system is a possible triage procedure to identify patients needing a colposcopy. Its specificity is better for women over 30.
Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T Geburtshilfe Frauenheilkd. 2019; 79(2):160-176.
PMID: 30792546 PMC: 6379166. DOI: 10.1055/a-0828-7722.
Catteau X, Simon P, Noel J ISRN Obstet Gynecol. 2014; 2014:536495.
PMID: 24693444 PMC: 3945153. DOI: 10.1155/2014/536495.
Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch P Cochrane Database Syst Rev. 2013; (3):CD008054.
PMID: 23543559 PMC: 6457841. DOI: 10.1002/14651858.CD008054.pub2.
Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J J Cell Mol Med. 2009; 13(4):648-59.
PMID: 19166485 PMC: 3822872. DOI: 10.1111/j.1582-4934.2008.00631.x.